It is a healthcare private limited company based in Mumbai, Maharashtra, India, established in 2022.
2022 | Mumbai, Maharashtra, India | ActiveHetairos Pharmaceuticals Private Limited, a active private limited company, was established on 18 January 2022 in Mumbai, Maharashtra, India. Engaging in medical appliances and instruments within the healthcare sector, it holds CIN: U33119MH2022PTC375079. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.10 M.
Its leadership includes Jitendra Yadav (Director), Varsha Suresh Gupta (Additional Director). Past directors included Mubin Khan. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Mmf 13 1/1 Bh Pritam Ceramics, Nr. Neeldurg Hotel, Mukti Nagar, Chembur, Mumbai, Maharashtra, 400088.
U33119MH2022PTC375079
375079
18 January 2022
₹0.50 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Hetairos Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jitendra Yadav | Director | 18 Jan 2022 | Current |
| Varsha Suresh Gupta | Additional Director | 02 Aug 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 21 Aug 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Hetairos Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Hetairos Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Hetairos Pharmaceuticals has a workforce of 0 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Hetairos Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hetairos Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Hetairos Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Varsha Suresh Gupta was appointed as a Additional Director was appointed as a Additional Director on 02 Aug 2024 & has been associated with this company since 1 year 3 months . was recorded as a recent event.
Progress on Hetairos Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.
Jitendra Yadav was appointed as a Director was appointed as a Director on 18 Jan 2022 & has been associated with this company since 3 years 10 months . was recorded as a recent event.
Progress on Hetairos Pharmaceuticals Private Limited was registered on 18 Jan 2022 with Roc Mumbai & aged 3 years 10 months as per MCA records. was documented.
The CIN of Hetairos Pharmaceuticals Private Limited is U33119MH2022PTC375079.
Hetairos Pharmaceuticals Private Limited is headquartered at Mmf 13 1/1 Bh Pritam Ceramics, Nr. Neeldurg Hotel, Mukti Nagar, Chembur, Mumbai, Maharashtra, 400088.
Hetairos Pharmaceuticals Private Limited was incorporated on 18 January 2022.
The current directors of Hetairos Pharmaceuticals Private Limited are
The primary industry of Hetairos Pharmaceuticals Private Limited is Healthcare.
Hetairos Pharmaceuticals Private Limited is unlisted.
The authorized capital of Hetairos Pharmaceuticals Private Limited is ₹0.50 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX